首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications.
【24h】

Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications.

机译:经导管主动脉瓣植入术的患者的麻醉和围手术期管理:分析90例以围手术期并发症为重点的连续患者。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To describe, from the point of view of anesthesia and intensive care specialists, the perioperative management of high-risk patients with aortic stenosis who underwent transcatheter (transfemoral and transapical) aortic valve implantation (TAVI). The authors specifically focused on immediate postoperative complications. DESIGN: Retrospective review of collected data. SETTING: Academic hospital. PARTICIPANTS: Ninety consecutive patients with severe aortic stenosis who underwent TAVI. INTERVENTIONS: General anesthesia followed by postoperative care. Complications were defined by pre-established criteria. MEASUREMENTS AND MAIN RESULTS: Of 184 patients referred between October 2006 and February 2009, 90 were consecutively treated with TAVI because of a high surgical risk or contraindications to surgery. The transfemoral approach was used as the first option (n = 62), and the transapical approach when contraindications to the former were present (n = 28). Results are presented as mean +/- standard deviation or median (25-75 percentiles) as appropriate. Patients were 81 +/- 8 years old, in New York Heart Association classes II (9%), III (54 %), or IV (37%); left ventricular ejection fraction was below 0.5 in 38% of patients. The predicted surgical mortality was 24% (16-32) and 15% (11-23) with the logistic EuroSCORE and STS-Predicted Risk of Mortality, respectively. The valve was implanted in 92% of the cases. The duration of anesthesia and (intra- and postoperative) mechanical ventilation was 190 (160-230) minutes and 245 (180-420) minutes, respectively. Hospital mortality was 11%. The most frequent cardiac complications were heart failure (20%) and atrioventricular block (16%), with 6% requiring a pacemaker. Vascular complications (major and minor) occurred in 29% of the patients. CONCLUSIONS: Despite their severe comorbidities, the mortality of the patients in this cohort was below that predicted by cardiac surgery risk scores. Monitoring, hemodynamic instability, and the frequency of complications require management and follow-up of these patients in similar ways as for open cardiac surgery. The frequency of complications in this cohort was comparable to that published by other groups.
机译:目的:从麻醉和重症监护专家的角度,描述经导管(经股动脉和经心尖)行主动脉瓣膜植入术(TAVI)的高危主动脉瓣狭窄患者的围手术期管理。作者专门研究了术后即刻并发症。设计:对收集的数据进行回顾性审查。地点:学术医院。参加者:连续90例患有严重主动脉瓣狭窄的患者接受了TAVI治疗。干预措施:全身麻醉后进行术后护理。并发症是通过预先确定的标准定义的。测量和主要结果:在2006年10月至2009年2月之间转诊的184例患者中,有90例因手术风险高或手术禁忌症而连续接受TAVI治疗。经股动脉入路被用作第一选择(n = 62),当存在与前者禁忌症时经经根尖入路(n = 28)。结果以适当的平均值+/-标准偏差或中位数(25-75%)表示。纽约心脏协会II级(9%),III级(54%)或IV级(37%)的患者年龄为81 +/- 8岁; 38%的患者左心室射血分数低于0.5。使用逻辑EuroSCORE和STS预测的死亡率风险,预测的手术死亡率分别为24%(16-32)和15%(11-23)。在92%的病例中植入了瓣膜。麻醉和(术中和术后)机械通气的持续时间分别为190(160-230)分钟和245(180-420)分钟。医院死亡率为11%。心脏并发症最常见的是心力衰竭(20%)和房室传导阻滞(16%),其中6%需要起搏器。 29%的患者发生血管并发症(主要和次要)。结论:尽管患有严重的合并症,但该队列患者的死亡率低于心脏手术风险评分所预测的死亡率。监测,血流动力学不稳定和并发症的发生频率要求这些患者以与心脏直视手术相似的方式进行管理和随访。在该队列中并发症发生的频率与其他组所公布的频率相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号